KNSA
Kiniksa Pharmaceuticals International, plc · Healthcare · Market cap $6.6B(Price slightly stale)
Insiders sold $668K net in the last 90 days ·2 sellers, 0 buyers· 1 of 2 sales under Rule 10b5-1 plans· latest Form 4 filed Sep 3, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$47.8M
reported sales (SEC code S)
Unique Insiders
8
in the rolling window
Latest filing
Sep 3, 2026
Megna Michael R
Kiniksa Pharmaceuticals International, plc (KNSA) has 52 SEC Form 4 filings (146 transaction rows) in the rolling window, disclosed by 8 distinct insiders. Most recent filing: Sep 3, 2026.
Inside the rolling window, 8 insiders at Kiniksa Pharmaceuticals International, plc reported no open-market purchases and 30 open-market sales totaling $47.8M. The most active filer is Director Quart Barry D with 8 filings. Insiders have net sold $36.4M over the trailing 6 months. The most recent open-market filing is a sale of 4,600 shares by CHIEF ACCOUNTING OFFICER Megna Michael R, dated Sep 3, 2026, worth $369K.
- Industry:Medical - Pharmaceuticals
- CEO:Sanj K. Patel
- Employees:366
- HQ:London, GL, GB
- IPO:2018-05-24
| Source | |||||||
|---|---|---|---|---|---|---|---|
Megna Michael RFirst in 5 months | CHIEF ACCOUNTING OFFICER | Sale | 4,600 | $369K | Sep 3 | -1.0% | SEC ↗ |
Cole G BradleyFirst in 5 months | Director | Sale | 3,673 | $299K | Jul 31 | +7.2% | SEC ↗ |
| CHIEF MEDICAL OFFICER | Sale | 58,424 | $3.1M | May 5 | +40.5% | SEC ↗ | |
| CHAIRMAN & CEO | Sale | 48,565 | $2.6M | May 1 | +44.2% | SEC ↗ | |
| CHAIRMAN & CEO | Sale | 483,654 | $25.1M | Apr 30 | +48.2% | SEC ↗ | |
| CHAIRMAN & CEO | Sale | 22,544 | $1.2M | Apr 30 | +48.2% | SEC ↗ | |
| CHAIRMAN & CEO | Sale | 2,141 | $116K | Apr 30 | — | SEC ↗ | |
| Director | Sale | 13,099 | $656K | Apr 29 | — | SEC ↗ | |
Megna Michael RFirst filing | CHIEF ACCOUNTING OFFICER | Sale | 6,625 | $309K | Apr 13 | — | SEC ↗ |
| CHIEF OPERATING OFFICER | Sale | 1,703 | $80K | Apr 13 | — | SEC ↗ | |
Patel Sanj KFirst filing | CHAIRMAN & CEO | Sale | 7,278 | $364K | Apr 8 | — | SEC ↗ |
Moat RossFirst filing | CHIEF OPERATING OFFICER | Sale | 2,367 | $115K | Apr 8 | — | SEC ↗ |
| Director | Sale | 6,901 | $345K | Apr 8 | — | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 36,722 | $1.7M | Mar 11 | — | SEC ↗ | |
Paolini John F.First in 4 months | CHIEF MEDICAL OFFICER | Sale | 40,000 | $1.8M | Mar 4 | — | SEC ↗ |
| Director | Sale | 110 | $5K | Feb 12 | — | SEC ↗ | |
| Director | Sale | 2,690 | $121K | Feb 12 | — | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 17,845 | $772K | Feb 11 | — | SEC ↗ | |
| Director | Sale | 830 | $37K | Feb 4 | — | SEC ↗ | |
| Director | Sale | 12,528 | $567K | Feb 4 | — | SEC ↗ | |
| Director | Sale | 2,602 | $117K | Feb 4 | — | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 12,000 | $503K | Jan 9 | — | SEC ↗ | |
Quart Barry DFirst filing | Director | Sale | 20,129 | $836K | Dec 17 | — | SEC ↗ |
| CHIEF OPERATING OFFICER | Sale | 12,048 | $501K | Dec 17 | — | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 42,841 | $1.8M | Dec 10 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does KNSA have?
Kiniksa Pharmaceuticals International, plc (KNSA) has 52 SEC Form 4 filings (146 transaction rows) in the rolling 365-day window, disclosed by 8 distinct insiders. Most recent filing: Sep 3, 2026.
When was the most recent SEC Form 4 filing for KNSA?
The most recent Form 4 filing for KNSA on Tracefour is dated Sep 3, 2026.
Who is the most active insider at KNSA?
The most active SEC Form 4 filer at KNSA in the rolling window is Director Quart Barry D, with 8 filings.
What is the net insider flow at KNSA over the last 6 months?
Over the trailing 180 days, insiders at KNSA have net sold $36.4M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at KNSA in the current window?
Inside the rolling window, insiders at KNSA bought $0 and sold $47.8M based on SEC Form 4 filings.
Can I get alerts for KNSA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Kiniksa Pharmaceuticals International, plc (KNSA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Kiniksa Pharmaceuticals International, plc is in the Healthcare sector.